Write in a clean editor, then format for Frontiers in Transplantation in one click — DocuGuru applies the official Frontiers template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Frontiers in Transplantation is a peer-reviewed journal published by Frontiers, covering Renal Transplantation Outcomes and Treatments, Organ Transplantation Techniques and Outcomes, Transplantation: Methods and Outcomes. Over its lifetime it has published 343 papers, which have received 1,070 citations.
| Publisher | Frontiers |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Frontiers in Transplantation. 2023;12(3):45–58.
Formats any DOI in Frontiers in Transplantation style. No sign-up. |
| Publishes research in | Renal Transplantation Outcomes and Treatments Organ Transplantation Techniques and Outcomes Transplantation: Methods and Outcomes Organ Donation and Transplantation Organ and Tissue Transplantation Research |
| ISSN | 2813-2440 |
| Citation impact (2-yr) | 1.75 |
| h-index | 13 |
| i10-index | 21 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Harvard University |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Autologous chimeric antigen receptor-modified T-cell (CAR T) products have demonstrated un-precedent efficacy in treating many relapsed/refractory B-cell and plasma cell malignancies, leading to multiple commercial products now in routine clinical use. These positive responses to CAR T therapy have spurred biotech and big pharma companies to evaluate innovative production methods to increase patient access while…
regulatory T cells (Tregs) are indispensable for preventing autoimmunity, and they play a role in cancer and transplantation settings by restraining immune responses. In this review, we describe evidence for the importance of Tregs in the induction versus maintenance of transplantation tolerance, discussing insights into mechanisms of Treg control of the alloimmune response. Further, we…
Modern tissue engineering has made substantial advancements that have revolutionized plastic surgery. Acellular dermal matrix (ADM) is an example that has gained considerable attention recently. ADM can be made from humans, bovines, or porcine tissues. ADM acts as a scaffold that incorporates into the recipient tissue. It is gradually infiltrated by fibroblasts and vascularized. Fortunately,…
The calcineurin inhibitor (CNI) Tacrolimus (Tac) is the most prescribed immunosuppressant drug after solid organ transplantation. After renal transplantation (RTx) approximately 95% of recipients are discharged with a Tac-based immunosuppressive regime. Despite the high immunosuppressive efficacy, its adverse effects, narrow therapeutic window and high intra- and interpatient variability (IPV) in pharmacokinetics require therapeutic drug monitoring…
